Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

1,459 trials

NCT07654972
Recruiting
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Phase 1 · Singapore, United States · 3 sites
Registry update: 15 Oct 2026
NCT07665879
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
Phase 1 · Germany, Sweden · 2 sites
Registry update: 16 Jul 2026
NCT07629544
Recruiting
A Study of DA-302168S in Participants With Overweight/Obesity
Phase 3 · China · 1 site
Registry update: 6 Aug 2026
NCT07331974
Recruiting
Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity
Not applicable · China · 1 site
Registry update: 9 Oct 2026
NCT07162337
Recruiting
BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
Not applicable · United States · 1 site
Registry update: 23 Jun 2026
NCT07748949
Recruiting
Effectiveness of a Low-Calorie Diet Combined With Intensive Lifestyle Intervention Using Integrated Personalized Diabetes Management for Achieving Diabetes Remission in Patients With Type 2 Diabetes Mellitus
Not applicable · Thailand · 1 site
Registry update: 6 Aug 2026
NCT07738029
Recruiting
OBE2026 - Effect of One Year Intensive Lifestyle Treatment in Children With ISO-BMI Over 30kg/m² and Their Families.
Not applicable · Finland · 1 site
Registry update: 30 Jul 2026
NCT07654179
Recruiting
Metformin as Adjunct Therapy in Depression-obesity Comorbidity: Clinical and Genetic Evaluation
Not applicable · Pakistan · 2 sites
Registry update: 7 Aug 2026
NCT07728383
Recruiting
A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
Phase 4 · United States · 1 site
Registry update: 27 Jul 2026
NCT07378072
Recruiting
Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
Not applicable · France · 9 sites
Registry update: 29 Jun 2026
NCT07364045
Recruiting
Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS)
Not applicable · United Kingdom · 1 site
Registry update: 18 Jun 2026
NCT07673900
Recruiting
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
Phase 1 · United States · 1 site
Registry update: 31 Jul 2026
NCT07581431
Recruiting
A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969
Phase 1 · Australia · 1 site
Registry update: 22 Jun 2026
NCT07702461
Recruiting
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Not applicable · United States · 1 site
Registry update: 24 Jul 2026
NCT07638241
Recruiting
Agentic AI Personalized Dietary Management Study
Not applicable · South Korea · 1 site
Registry update: 15 Sept 2026
NCT07595549
Recruiting
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Phase 3 · Brazil, Canada, Germany, Spain, France, Italy, Japan, South Korea, Mexico, Poland, United States · 81 sites
Registry update: 5 Nov 2026
NCT07654439
Recruiting
Validity and Reliability of Mixed Reality-Based Performance Tests in Overweight and Obese Adults
Not applicable · 1 site
Registry update: 17 Jun 2026
NCT07517042
Recruiting
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
Not applicable · China · 13 sites
Registry update: 22 Oct 2026
NCT07257484
Recruiting
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Phase 4 · United States · 1 site
Registry update: 22 Jul 2026
NCT07657286
Recruiting
Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients
Not applicable · Egypt · 1 site
Registry update: 18 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.